ITRM logo

Iterum Therapeutics (ITRM) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$24.13 M
+$18.05 M+297.38%

December 31, 2024


Summary


Performance

ITRM Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$24.13 M
+$10.72 M+79.96%

December 1, 2024


Summary


Performance

ITRM Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherITRMbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ITRM Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+297.4%+80.0%
3 y3 years-12.1%+80.0%
5 y5 years+402.5%+80.0%

ITRM Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.1%+297.4%-23.1%+400.9%
5 y5-year-12.1%+402.5%-63.8%+402.5%
alltimeall time-45.9%+402.5%-71.6%+402.5%

Iterum Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$24.13 M(+297.4%)
-
Dec 2024
-
$24.13 M(+80.0%)
Sep 2024
-
$13.41 M(+169.4%)
Jun 2024
-
$4.98 M(-32.7%)
Mar 2024
-
$7.39 M(+21.7%)
Dec 2023
$6.07 M(-71.2%)
$6.07 M(+26.1%)
Sep 2023
-
$4.82 M(-64.9%)
Jun 2023
-
$13.73 M(-18.4%)
Mar 2023
-
$16.83 M(-20.2%)
Dec 2022
$21.09 M(-23.2%)
$21.09 M(+2.9%)
Sep 2022
-
$20.49 M(+122.5%)
Jun 2022
-
$9.21 M(-70.6%)
Mar 2022
-
$31.36 M(+14.3%)
Dec 2021
$27.45 M
$27.45 M(-23.7%)
Sep 2021
-
$35.98 M(-1.6%)
DateAnnualQuarterly
Jun 2021
-
$36.57 M(-45.1%)
Mar 2021
-
$66.64 M(+359.3%)
Dec 2020
$14.51 M(+202.2%)
$14.51 M(+69.3%)
Sep 2020
-
$8.57 M(-30.0%)
Jun 2020
-
$12.25 M(-47.3%)
Mar 2020
-
$23.26 M(+384.4%)
Dec 2019
$4.80 M(-89.2%)
$4.80 M(-83.4%)
Sep 2019
-
$28.88 M(-43.6%)
Jun 2019
-
$51.24 M(-20.7%)
Mar 2019
-
$64.60 M(+45.0%)
Dec 2018
$44.55 M(+425.1%)
$44.55 M(+12.5%)
Sep 2018
-
$39.60 M(-53.4%)
Jun 2018
-
$84.90 M(+121.9%)
Mar 2018
-
$38.26 M(+350.9%)
Dec 2017
$8.48 M(-65.8%)
$8.48 M
Dec 2016
$24.81 M
-

FAQ

  • What is Iterum Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Iterum Therapeutics?
  • What is Iterum Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Iterum Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Iterum Therapeutics?
  • What is Iterum Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Iterum Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of ITRM is $24.13 M

What is the all time high annual cash & cash equivalents for Iterum Therapeutics?

Iterum Therapeutics all-time high annual cash & cash equivalents is $44.55 M

What is Iterum Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, ITRM annual cash & cash equivalents has changed by +$18.05 M (+297.38%)

What is Iterum Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ITRM is $24.13 M

What is the all time high quarterly cash and cash equivalents for Iterum Therapeutics?

Iterum Therapeutics all-time high quarterly cash and cash equivalents is $84.90 M

What is Iterum Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, ITRM quarterly cash and cash equivalents has changed by +$10.72 M (+79.96%)